NVET
Nexvet Biopharma plc Ordinary Shares
NVET
NVET
Delisted
NVET was delisted on the 28th of July, 2017.
13 hedge funds and large institutions have $22.6M invested in Nexvet Biopharma plc Ordinary Shares in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
-5
Holders Change %
-27.78%
% of All Funds
0.32%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
1
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citigroup
New York
|
+$1.15K |
Top Sellers
| 1 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$68.3K |
| 2 |
CI
Cowen Inc
New York
|
-$43K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$26.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$4K |
